Qkine, a leading recombinant protein manufacturer, and Tolemy Bio, a pioneer in custom cell culture media design using AI, are excited to announce a collaborative partnership to drive innovation in cell and gene therapy (CGT) manufacturing.
Qkine Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, and REPROCELL Inc., Japan’s first and leading induced pluripotent stem cell (iPSC) company, have partnered to globally distribute high-quality proteins such as growth factors and cytokines manufactured by Qkine.
We are delighted to share that Culturon and Qkine have joined forces to deliver cutting-edge solutions for the stem cell and life science industries.
Through its pioneering cell-type-specific immortalization technology, inscreenex empowers scientists to overcome the limitations of primary cell cultures, offering long-lasting and functional cell lines that are ideal for applications in drug discovery, disease modeling, and personalized medicine. Collaboration with Qkine merges their expertise with that of Qkine in complex protein manufacturing and engineering to allow testing and validation of cell responses in disease modelling.
Qkine, a leading manufacturer of high purity bioactive proteins, is pleased to announce its new sales distribution agreement with leading Turkish cell biology and stem cell reagent supplier Pitagen.
Qkine is pleased to announce a new UK & Ireland sales distribution agreement with SLS, the largest independent supplier of laboratory equipment, chemicals, and consumables in the UK.
Qkine wins 'Scale-up of the Year' at the 2024 Cambridge Independent Business Awards On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the [...]
Qkine is pleased to announce a new global sales distribution agreement with AI driven digital research platform Scientist.com on their Product Hub Marketplace.
Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science [...]
Qkine is pleased to announce that it has successfully been recertified with the international standard ISO 9001:2015 by the globally respected UKAS accredited BSI, giving enhanced confidence in the assessment of best practices. This standard shows our dedication to raising the standard of bioactive proteins through implementation of continual improvement, scientific innovation and exceptional scientific and customer support
© 2024 Qkine Ltd. Company number 10470662 registered in England and Wales. All rights reserved
